# Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

> **NCT00469053** · PHASE1 · TERMINATED · sponsor: **Grünenthal GmbH** · enrollment: 36 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT00469053
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 36 (ESTIMATED)
- **Why stopped:** The trail end was achived according to the definition in the trial protocol
- **Last updated:** 2007-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469053, "Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00469053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*